Publications

Home 9 Publication 9 A New Wave of Collaboration Among Biotech Companies

A New Wave of Collaboration Among Biotech Companies

September 23, 2002

Reprinted with permission by The Licensing Journal, September 2002


Despite recent declines in the biotech stock index, the biotechnology industry as a whole is reasonably well capitalized and in good health. More biotechnology companies are profitable than ever before, and many have the financial reserves to make it through the next couple of years, even if the IPO market does not become more receptive to biotech offerings. To capitalize on this financial strength, biotech companies are collaborating more frequently with each other, and collaborating in new ways with the large pharmaceutical companies (Pharma).

Resources

Firm Highlights